Skip to content
value.today
Rapid Micro Biosystems Inc. logo

Rapid Micro Biosystems Inc.

Total raised
$129 M
7 rounds on record
Latest round
$60 M
Apr 2018
First round on record
Jul 2009
Today
Went public
See the company page

Rapid Micro Biosystems Inc. is listed today as Rapid Micro Biosystems, Inc.: market value, financials and filings are on its company page.

Funding rounds

7 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Rapid Micro Biosystems Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2018$60 MNo. 7$50 to $250 million

Rapid Micro Biosystems Inc.: Raise no. 7, Apr 2018

Investors in this round

11 investors had bought by the notice of Aug 14, 2019: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rapid Micro Biosystems Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$60 M of $60 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robert Spignesi · Executive Officer, Director
  • Sean Wirtjes · Executive Officer
  • Bruce Cohen · Director
  • Christopher Cashman · Director
  • David Hirsch · Director
  • Jeffrey Schwartz · Director
  • Natale Ricciardi · Director
  • Richard Kollender · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sean Wirtjes, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Aug 14, 2019. Read the notice at the SEC.

equitySEC
Apr 2015$19 MNo. 6$10 to $50 million

Rapid Micro Biosystems Inc.: Raise no. 6, Apr 2015

Investors in this round

18 investors had bought by the notice of May 4, 2015: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rapid Micro Biosystems Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$19 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robert Spignesi · Executive Officer, Director
  • Christopher M. Cashman · Director
  • David M. Hirsch · Director
  • Fred M. Cohen · Director
  • Richard S. Kollender · Director
  • Tom S. Monath · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert Spignesi, President and CEO. Source: SEC Form D, newest notice filed May 4, 2015. Read the notice at the SEC.

equitySEC
Apr 2014$6 MNo. 5$2 to $10 million

Rapid Micro Biosystems Inc.: Raise no. 5, Apr 2014

Investors in this round

9 investors had bought by the notice of Apr 11, 2014: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rapid Micro Biosystems Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$6 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael J. Mullen · Executive Officer
  • Stephen H. Delity · Executive Officer, Director
  • Christopher M. Cashman · Director
  • David M. Hirsch · Director
  • Fred M. Cohen · Director
  • Richard S. Kollender · Director
  • Tom S. Monath · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen H. Delity, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 11, 2014. Read the notice at the SEC.

equitySEC
Jun 2013$22 MNo. 4$10 to $50 million

Rapid Micro Biosystems Inc.: Raise no. 4, Jun 2013

Investors in this round

10 investors had bought by the notice of Jul 9, 2013: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rapid Micro Biosystems Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$22 M of $33 M offered; $11 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael J Mullen · Executive Officer
  • Stephen H Delity · Executive Officer, Director
  • Christopher M Cashman · Director
  • David J Hirsch · Director
  • Donald J Straus · Director
  • Mark G Cipriano · Director
  • Mark J Braganza · Director
  • Richard J Kollender · Director
  • Thomas P Monath · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael J. Mullen, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 9, 2013. Read the notice at the SEC.

equitySEC
Nov 2012$1 MNo. 3Under $2 million

Rapid Micro Biosystems Inc.: Raise no. 3, Nov 2012

Investors in this round

4 investors had bought by the notice of Nov 13, 2012: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rapid Micro Biosystems Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael J. Mullen · Executive Officer
  • Stephen M. Delity · Executive Officer, Director
  • Christopher M. Cashman · Director
  • Don S. Straus · Director
  • Mark G. Cipriano · Director
  • Richard S. Kollender · Director
  • Thomas P. Monath · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Steve Delity, President and CEO. Source: SEC Form D, newest notice filed Nov 13, 2012. Read the notice at the SEC.

debt, optionsSEC
Apr 2012$3 MNo. 2$2 to $10 million

Rapid Micro Biosystems Inc.: Raise no. 2, Apr 2012

Investors in this round

4 investors had bought by the notice of Apr 26, 2012: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rapid Micro Biosystems Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$3 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael J. Mullen · Executive Officer
  • Stephen M. Delity · Executive Officer, Director
  • Christopher M. Cashman · Director
  • Don S. Straus · Director
  • Mark G. Cipriano · Director
  • Richard S. Kollender · Director
  • Thomas P. Monath · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Steve Delity, President and CEO. Source: SEC Form D, newest notice filed Apr 26, 2012. Read the notice at the SEC.

debt, optionsSEC
Jul 2009$19 MNo. 1$10 to $50 million

Rapid Micro Biosystems Inc.: Raise no. 1, Jul 2009

Investors in this round

9 investors had bought by the notice of Jul 15, 2009: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rapid Micro Biosystems Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$19 M of $19 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Donald Straus · Executive Officer, Director
  • Michael Ellis · Executive Officer
  • Stephen Delity · Executive Officer, Director
  • Lorin Randall · Director
  • William Moffitt · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael J. Ellis, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 15, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Rapid Micro Biosystems Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2019).

    SEC Form D · Aug 2019

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Aug 2019

That is all the official record says: Rapid Micro Biosystems Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Rapid Micro Biosystems Inc. are on record.

Investors#

7 named in official filings. Open an investor to see everything it has backed.

Investors in Rapid Micro Biosystems Inc.
InvestorKindAmountRoundRoleSource
Bain Capital Life Sciences Fund, L.P.Fund or asset managernot statednot statedHeld Series B1 and C1 preferred stock, 10% owner (Form 3, 2021)SEC Form 3
Bain Capital Life Sciences Investors, LLCFund or asset managernot statednot statedHeld Series B1 and C1 preferred stock, 10% owner (Form 3, 2021)SEC Form 3
Bain Capital Life Sciences Partners, LPFund or asset managernot statednot statedHeld Series B1 and C1 preferred stock, 10% owner (Form 3, 2021)SEC Form 3
BCIP Life Sciences Associates, LPFund or asset managernot statednot statedHeld Series B1 and C1 preferred stock, 10% owner (Form 3, 2021)SEC Form 3
Gurinder GrewalPersonnot statednot statedHeld Series D1 preferred stock, 10% owner (Form 3, 2021)SEC Form 3
Longitude Capital Partners II, LLCFund or asset managernot statednot statedHeld Series A1, B1 and C1 preferred stock, 10% owner (Form 3, 2021)SEC Form 3
Longitude Venture Partners II, L.P.Venture capitalnot statednot statedHeld Series A1, B1 and C1 preferred stock, 10% owner (Form 3, 2021)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 7 rounds above had up to 18 investors.

Largest shareholders today

Institutions holding Rapid Micro Biosystems, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Rapid Micro Biosystems Inc.
NameRoleNamed in
Robert SpignesiExecutive officerAug 2019
Sean WirtjesExecutive officerAug 2019
Richard KollenderExecutive officerMay 2018
Michael J. MullenExecutive officerApr 2014
Stephen H. DelityExecutive officerApr 2014
Michael J MullenExecutive officerJul 2013
Stephen H DelityExecutive officerJul 2013
Stephen M. DelityExecutive officerNov 2012
Donald StrausExecutive officerJul 2009
Michael EllisExecutive officerJul 2009
Stephen DelityExecutive officerJul 2009
Bruce CohenDirectorAug 2019
Christopher CashmanDirectorAug 2019
David HirschDirectorAug 2019
Jeffrey SchwartzDirectorAug 2019
Natale RicciardiDirectorAug 2019
Richard KollenderDirectorAug 2019
Robert SpignesiDirectorAug 2019
Bruce M. CohenDirectorMay 2018
Christopher M. CashmanDirectorMay 2018
David M. HirschDirectorMay 2018
Jeffrey M. SchwartzDirectorMay 2018
Luc Sherrill MarengereDirectorMay 2018
Natale M. RicciardiDirectorMay 2018
P. Sherrill NeffDirectorMay 2018
Fred M. CohenDirectorMay 2015
Richard S. KollenderDirectorMay 2015
Tom S. MonathDirectorMay 2015
Stephen H. DelityDirectorApr 2014
Christopher M CashmanDirectorJul 2013
David J HirschDirectorJul 2013
Donald J StrausDirectorJul 2013
Mark G CiprianoDirectorJul 2013
Mark J BraganzaDirectorJul 2013
Richard J KollenderDirectorJul 2013
Stephen H DelityDirectorJul 2013
Thomas P MonathDirectorJul 2013
Don S. StrausDirectorNov 2012
Mark G. CiprianoDirectorNov 2012
Stephen M. DelityDirectorNov 2012

Went public since 2021. Its SEC number is that of a company listed on a stock exchange.